Table 3: Distribution of HIV/hepatitis co-infection in patients under second-line ARVs by town and center.
Town | Center | HIV | HIV/HBV | HIV/HCV | HIV/HBV/HCV | Total |
N (%) | N (%) | N (%) | N (%) | N (%) | ||
Pointe-Noire | CTA-PN | 44 (78.57) | 4 (7.14) | 8 (14.29) | 0 | 56 (50.91) |
HBTT | 25 (86.21) | 1 (3.45) | 3 (10.34) | 0 | 29 (26.36) | |
HGAS | 25 (100) | 0 | 0 | 0 | 25 (22.73) | |
Total | 94 (85.45) | 5 (4.55) | 11 (10) | 0 | 110 (100) | |
Brazzaville | CTA-BZV | 98 (89.09) | 6 (5.45) | 5 (4.55) | 1 (0.91) | 110 (72.85) |
CMS-EEC | 39 (95.12) | 0 | 2 (4.88) | 0 | 41 (27.15) | |
Total | 137 (90.73) | 6 (3.97) | 7 (4.64) | 1 (0.66) | 151 (100) |